Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Impact of Aflibercept Dosing Frequency on Retinal Nonperfusion Progression Assessed by Ultra-Widefield Angiography After Endolaserless Vitrectomy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.
Journal: Journal of vitreoretinal diseases
Published: May 21, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III INSIGHT randomized clinical trial.
Journal: Expert opinion on biological therapy
Published: May 08, 2026
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.
Journal: JAMA ophthalmology
Published: March 06, 2025
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.
Journal: JAMA ophthalmology
Published: September 12, 2024
Clinical Performance of Semi-Automated Spectral-Domain Optical Coherence Tomography Angiography.
Journal: Journal of clinical medicine
Published: September 04, 2024
Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA.
Journal: Ophthalmology. Retina
Published: June 12, 2024
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial.
Journal: Ophthalmology science
Published: January 05, 2024
Reply to Letter to the Editor: Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: October 17, 2023
Complications, Compliance, and 3-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: February 13, 2023
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
Journal: JAMA ophthalmology
Published: August 18, 2022
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
Journal: JAMA ophthalmology
Published: August 18, 2022
Last Updated: 09/26/2026